rs5900

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2

The NM_000506.5(F2):​c.1602G>A​(p.Pro534Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0202 in 1,613,962 control chromosomes in the GnomAD database, including 402 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.015 ( 22 hom., cov: 32)
Exomes 𝑓: 0.021 ( 380 hom. )

Consequence

F2
NM_000506.5 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: -2.59

Publications

8 publications found
Variant links:
Genes affected
F2 (HGNC:3535): (coagulation factor II, thrombin) This gene encodes the prothrombin protein (also known as coagulation factor II). This protein is proteolytically cleaved in multiple steps to form the activated serine protease thrombin. The activated thrombin enzyme plays an important role in thrombosis and hemostasis by converting fibrinogen to fibrin during blood clot formation, by stimulating platelet aggregation, and by activating additional coagulation factors. Thrombin also plays a role in cell proliferation, tissue repair, and angiogenesis as well as maintaining vascular integrity during development and postnatal life. Peptides derived from the C-terminus of this protein have antimicrobial activity against E. coli and P. aeruginosa. Mutations in this gene lead to various forms of thrombosis and dysprothrombinemia. Rapid increases in cytokine levels following coronavirus infections can dysregulate the coagulation cascade and produce thrombosis, compromised blood supply, and organ failure. [provided by RefSeq, May 2020]
F2 Gene-Disease associations (from GenCC):
  • thrombophilia due to thrombin defect
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae)
  • congenital prothrombin deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 11-46729509-G-A is Benign according to our data. Variant chr11-46729509-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 256313.
BP7
Synonymous conserved (PhyloP=-2.59 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0153 (2333/152212) while in subpopulation NFE AF = 0.0252 (1711/68002). AF 95% confidence interval is 0.0242. There are 22 homozygotes in GnomAd4. There are 1098 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 22 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000506.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
F2
NM_000506.5
MANE Select
c.1602G>Ap.Pro534Pro
synonymous
Exon 12 of 14NP_000497.1P00734

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
F2
ENST00000311907.10
TSL:1 MANE Select
c.1602G>Ap.Pro534Pro
synonymous
Exon 12 of 14ENSP00000308541.5P00734
F2
ENST00000862106.1
c.1698G>Ap.Pro566Pro
synonymous
Exon 13 of 15ENSP00000532165.1
F2
ENST00000862118.1
c.1650G>Ap.Pro550Pro
synonymous
Exon 12 of 14ENSP00000532177.1

Frequencies

GnomAD3 genomes
AF:
0.0153
AC:
2332
AN:
152094
Hom.:
22
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00430
Gnomad AMI
AF:
0.0186
Gnomad AMR
AF:
0.00898
Gnomad ASJ
AF:
0.0121
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00249
Gnomad FIN
AF:
0.0194
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0252
Gnomad OTH
AF:
0.0134
GnomAD2 exomes
AF:
0.0156
AC:
3911
AN:
251364
AF XY:
0.0153
show subpopulations
Gnomad AFR exome
AF:
0.00437
Gnomad AMR exome
AF:
0.00674
Gnomad ASJ exome
AF:
0.00913
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0200
Gnomad NFE exome
AF:
0.0255
Gnomad OTH exome
AF:
0.0155
GnomAD4 exome
AF:
0.0207
AC:
30320
AN:
1461750
Hom.:
380
Cov.:
31
AF XY:
0.0204
AC XY:
14813
AN XY:
727158
show subpopulations
African (AFR)
AF:
0.00370
AC:
124
AN:
33480
American (AMR)
AF:
0.00758
AC:
339
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00907
AC:
237
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.00292
AC:
252
AN:
86256
European-Finnish (FIN)
AF:
0.0210
AC:
1123
AN:
53392
Middle Eastern (MID)
AF:
0.00850
AC:
49
AN:
5768
European-Non Finnish (NFE)
AF:
0.0244
AC:
27122
AN:
1111910
Other (OTH)
AF:
0.0178
AC:
1074
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
1666
3332
4999
6665
8331
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
952
1904
2856
3808
4760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0153
AC:
2333
AN:
152212
Hom.:
22
Cov.:
32
AF XY:
0.0148
AC XY:
1098
AN XY:
74412
show subpopulations
African (AFR)
AF:
0.00428
AC:
178
AN:
41546
American (AMR)
AF:
0.00897
AC:
137
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.0121
AC:
42
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00270
AC:
13
AN:
4822
European-Finnish (FIN)
AF:
0.0194
AC:
206
AN:
10600
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0252
AC:
1711
AN:
68002
Other (OTH)
AF:
0.0133
AC:
28
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
119
237
356
474
593
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0228
Hom.:
88
Bravo
AF:
0.0147
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.0238
EpiControl
AF:
0.0258

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Congenital prothrombin deficiency (2)
-
-
1
not specified (1)
-
1
-
Thrombophilia due to thrombin defect (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
0.33
DANN
Benign
0.58
PhyloP100
-2.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5900; hg19: chr11-46751059; API